Skye Bioscience Announces Departure of CFO Kaitlyn Arsenault
PUBLIC · SKYEFeb 20, 2026
Position
Executive Officer
Company
Skye Bioscience
Kaitlyn Arsenault
San DiegoBiotechnologyHealthcare
Description
On February 13, 2026, Skye Bioscience announced the departure of Kaitlyn Arsenault from her role as Chief Financial Officer. Ms. Arsenault will step down effective February 20, 2026, to pursue new professional opportunities
Who to call at Skye Bioscience, and when
A new leader at Skye Bioscience brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Skye Bioscience raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Skye Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Skye Bioscience. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Skye Bioscience
Location
11250 EL CAMINO REAL, SUITE 100
San Diego, California, United States
About
Skye Bioscience, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system. With a focus on obesity and ocular indications, Skye is dedicated to unlocking the pharmaceutical potential of the endocannabinoid system to treat diseases with metabolic, inflammatory, and fibrotic processes.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Skye Bioscience changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San DiegoBiotechnologyHealthcare